Evidence map›Paper›PMID 25704483›Full record

ArticleJournal of cellular and molecular medicine2015

Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease.

Sorina Georgiana Boaru, Uta Merle, Ricarda Uerlings, Astrid Zimmermann, Christa Flechtenmacher, Claudia Willheim, Elisabeth Eder, Peter Ferenci, Wolfgang Stremmel, Ralf Weiskirchen

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Current Management of Neurological Wilson's Disease.Tremor and other hyperkinetic movements (New York, N.Y.) · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Animal models of Wilson disease.Journal of neurochemistry · 2018
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Sorina Georgiana BoaruInstitute of Molecular Pathobiochemistry, Experimental Gene Therapie and Clinical Chemistry, RWTH Aachen University Hospital Aachen, Aachen, Germany.
Uta Merle
Ricarda Uerlings
Astrid Zimmermann
Christa Flechtenmacher
Claudia Willheim
Elisabeth Eder
Peter Ferenci
Wolfgang Stremmel
Ralf Weiskirchen
Medical University of Vienna · ATHeidelberg University · DEUniversitätsklinikum Aachen · DERWTH Aachen University · DEUniversity Hospital Heidelberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wilson's disease is an autosomal recessive disorder in which the liver does not properly release copper into bile, resulting in prominent copper accumulation in various tissues. Affected patients suffer from hepatic disorders and severe neurological defects. Experimental studies in mutant mice in which the copper-transporting ATPase gene (Atp7b) is disrupted revealed a drastic, time-dependent accumulation of hepatic copper that is accompanied by formation of regenerative nodes resembling cirrhosis. Therefore, these mice represent an excellent exploratory model for Wilson's disease. However, the precise time course in hepatic copper accumulation and its impact on other trace metals within the liver is yet poorly understood. We have recently established novel laser ablation inductively coupled plasma mass spectrometry protocols allowing quantitative metal imaging in human and murine liver tissue with high sensitivity, spatial resolution, specificity and quantification ability. By use of these techniques, we here aimed to comparatively analyse hepatic metal content in wild-type and Atp7b deficient mice during ageing. We demonstrate that the age-dependent accumulation of hepatic copper is strictly associated with a simultaneous increase in iron and zinc, while the intrahepatic concentration and distribution of other metals or metalloids is not affected. The same findings were obtained in well-defined human liver samples that were obtained from patients suffering from Wilson's disease. We conclude that in Wilson's disease the imbalances of hepatic copper during ageing are closely correlated with alterations in intrahepatic iron and zinc content.

Indexed as

Laser TherapyAdenosine TriphosphatasesAdolescentAnimalsBase SequenceBlotting, WesternCation Transport ProteinsCopperCopper-Transporting ATPasesDiagnostic ImagingDisease Models, AnimalDNA Mutational AnalysisFemaleHepatolenticular DegenerationHumansInterleukin-1betaAdenosine TriphosphatasesATP7B protein, humanCation Transport ProteinsCopperCopper-Transporting ATPasesInterleukin-1betaIronMetalsTissue Inhibitor of Metalloproteinase-1Zinclaser ablation inductively coupled plasma mass spectrometrylivermetal bio-imagingtrace metalsWilson's disease

Identifiers

PMID25704483
PMCPMC4395195
OpenAlexW1973876918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.